These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 17979497)

  • 61. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of connective tissue growth factor in extracellular matrix degradation in renal tubular epithelial cells.
    Zhang C; Zhu Z; Liu J; Yang X; Fu L; Deng A
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):44-7. PubMed ID: 17393107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.
    Keski-Oja J; Raghow R; Sawdey M; Loskutoff DJ; Postlethwaite AE; Kang AH; Moses HL
    J Biol Chem; 1988 Mar; 263(7):3111-5. PubMed ID: 3125175
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells.
    Samarakoon R; Higgins PJ
    Thromb Haemost; 2008 Dec; 100(6):976-83. PubMed ID: 19132220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
    Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
    Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
    Thalacker FW; Nilsen-Hamilton M
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor.
    Campbell IK; Wojta J; Novak U; Hamilton JA
    Biochim Biophys Acta; 1994 Jul; 1226(3):277-85. PubMed ID: 8054359
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The significance of colocalization of plasminogen activator inhibitor-1 and vitronectin in hepatic fibrosis.
    Inuzuka S; Ueno T; Torimura T; Tamaki S; Sugawara H; Sakata R; Kusaba N; Sata M; Tanikawa K
    Scand J Gastroenterol; 1997 Oct; 32(10):1052-60. PubMed ID: 9361180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H; Zhang Y; Heuckeroth RO
    FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.
    Oda T; Jung YO; Kim HS; Cai X; López-Guisa JM; Ikeda Y; Eddy AA
    Kidney Int; 2001 Aug; 60(2):587-96. PubMed ID: 11473641
    [TBL] [Abstract][Full Text] [Related]  

  • 71. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
    Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
    J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.
    Bonniaud P; Kolb M; Galt T; Robertson J; Robbins C; Stampfli M; Lavery C; Margetts PJ; Roberts AB; Gauldie J
    J Immunol; 2004 Aug; 173(3):2099-108. PubMed ID: 15265946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Yamagami Y; Kawami M; Ojima T; Futatsugi S; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2020 May; 525(3):543-548. PubMed ID: 32113686
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism.
    Hattori N; Mizuno S; Yoshida Y; Chin K; Mishima M; Sisson TH; Simon RH; Nakamura T; Miyake M
    Am J Pathol; 2004 Mar; 164(3):1091-8. PubMed ID: 14982862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
    Sato M; Kawana K; Adachi K; Fujimoto A; Yoshida M; Nakamura H; Nishida H; Inoue T; Taguchi A; Takahashi J; Kojima S; Yamashita A; Tomio K; Nagamatsu T; Wada-Hiraike O; Oda K; Osuga Y; Fujii T
    Int J Oncol; 2016 Feb; 48(2):829-35. PubMed ID: 26676222
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells.
    Watanabe A; Kurabayashi M; Arai M; Sekiguchi K; Nagai R
    Cardiovasc Res; 2001 Jul; 51(1):151-9. PubMed ID: 11399257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
    Sipley JD; Alexander DS; Testa JE; Quigley JP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2933-8. PubMed ID: 9096324
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.
    Sawdey M; Podor TJ; Loskutoff DJ
    J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.